Delivery Order SPE2DR25D3501-SPE2DR26FM3BA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) with a completion date of February 3, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $28,553.91 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 15, 2025, with completion expected by January 7, 2026. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,722.86 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order was established on January 13, 2026, with an ultimate completion date of February 4, 2026. The contractor will perform from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on December 18, 2025, for Voranigo 40 mg tablets (30-count packages) with a ceiling value of $57,107.82. This firm fixed price, non-set-aside delivery order is scheduled for completion by January 12, 2026, and represents a direct pharmaceutical supply to support federal medical procurement needs. The award is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $28,553.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 16, 2025, with an ultimate completion date of January 8, 2026. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $56.7K to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on January 6, 2026, with completion expected by January 28, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare needs,...
- The Defense Logistics Agency awarded a delivery order valued at $26,231.49 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract. The award was issued on November 12, 2025, with an ultimate completion date of December 4, 2025, and utilizes no set-aside designation, indicating competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $27,094.95. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,556.64 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed price contract. The award was made on December 17, 2025, with an ultimate completion date of January 9, 2026, and represents a non-competitive, non-set-aside procurement. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM3BADelivery Order
The Defense Logistics Agency awarded a $28.4K delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract. The order, issued on January 26, 2026, carries an ultimate completion date of February 17, 2026 and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal military and veteran healthcare systems. The company operates as a child entity under parent company Cencora, Inc. (doing business as AmerisourceBergen), which manages significant federal pharmaceutical procurement relationships. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a substantial vehicle valued at approximately $1 billion through December 2026. This IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products, vaccines, medical devices, and healthcare commodities to support military treatment facilities and Defense Health Agency requirements globally. The award reflects the contractor's demonstrated capability to meet federal procurement standards through open competition and supports the broader federal objective of ensuring reliable pharmaceutical supply chains for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 1/25/26 |